Blood tumour mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multiple myeloma

Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour hot in prostate cancer

Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures

Blood test may identify patients with non-small cell lung cancer subtype who can benefit from combination therapy

Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype